Ujin Pharma Limited Files DRHP For IPO With SEBI: Check Key Issue Details

Ujin Pharma Limited has filed the Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) on June 22, 2026, seeking approval for a 100% book-built initial Public Offering (IPO).

The IPO comprises a total of 1.92 crore equity shares, consisting of a Fresh Issue of up to 1.19 crore shares and an Offer for Sale (OFS) of up to 0.73 crore shares, each carrying a face value of ?10. The OFS component will see promoters Jinesh Rasiklal Sheth and Umang Ketan Mehta offloading up to 36,41,150 shares each. Upon completion of the offering, the shares are proposed to be listed on both BSE and NSE.

Specific details of the price band, lot size, Anchor Investor bidding date, and public subscription opening and closing dates are yet to be announced.

Ujin Pharma IPO - Issue Details

• Issue Type: Book Building IPO (Fresh Issue + OFS)
• Total Issue Size: Up to 1.92 crore equity shares
• Fresh Issue: Up to 1.19 crore equity shares
• Offer for sale (OFS): Up to 0.73 crore equity shares
• Face Value: ? 10 per equity share
• Price Band: To be announced
• Lot Size: To be announced
• Listing: BSE, NSE
• Book Building Lead Managers: SMC Capitals Limited and Marwadi Chandarana Intermediaries Brokers Private Limited
• Registrar: KFin Technologies Limited?

Explore other Upcoming IPOs on BSE and NSE.

Utilisation of IPO Proceeds

The Company proposes to utilise the Net Proceeds from the Fresh Issue towards the following purposes:

• Investment in Altra Agro-Chem Private Limited, an associate company, by way of subscription to equity shares to make it a subsidiary
• Investment in Altra Pharma-Chem Private Limited, an associate company, by way of subscription to equity shares to make it a subsidiary.
• Repayment or pre-payment, in part or in full, of certain borrowings availed by the Company from financial institutions.
• General Corporate Purposes.

Check out newly Listed IPOs on BSE and NSE.

About Ujin Pharma Limited

Incorporated in 2024, Ujin Pharma Limited is a chemical distribution company specialising in solvents, speciality chemicals, acids, monomers, pharmaceutical raw materials, and nutraceuticals, serving industries ranging from pharmaceuticals and agrochemicals to paints, packaging, and petrochemicals.

The company operates a procurement network of 447 suppliers across 15+ countries, with 17 warehouses in Maharashtra and Gujarat. It has supplied approximately 8.53 lakh MT of chemicals to 3,000+ customers over the last three fiscal years. Through its subsidiary SSOPL, Ujin Pharma has expanded into solvent recycling, recovery, and the manufacturing of printing chemicals at its Pune facility.

Financial Performance

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here